Cross-Neutralization of Human Papillomavirus Types
Author Information
Author(s): Conway Michael J., Cruz Linda, Alam Samina, Christensen Neil David, Meyers Craig
Primary Institution: The Pennsylvania State University College of Medicine
Hypothesis
Is cross-neutralization of other HPV types dependent on the time of tissue harvest?
Conclusion
The study found that multiple anti-L2 antibodies could cross-neutralize HPV16, HPV31, and HPV18, but HPV45 was resistant to neutralization.
Supporting Evidence
- HPV16 L2 epitopes were only exposed in 20-day virions.
- HPV31 and HPV18 L2 epitopes were exposed in 10-day virions.
- HPV45 was not cross-neutralized by any of the anti-HPV16 L2 antibodies.
Takeaway
This study shows that some HPV types can be neutralized by antibodies, but others, like HPV45, cannot be neutralized at all.
Methodology
Neutralization assays were performed using antibodies against L2 epitopes from HPV types in organotypic cultures.
Limitations
The study did not explore the mechanisms behind the increased infectivity observed with some antibodies.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website